VISTAGEN THERAPEUTICS, INC. Debt Securities, Available-for-sale
VISTAGEN THERAPEUTICS, INC. (VTGN) had Debt Securities, Available-for-sale of $97.58 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2025-06-17
- 2024-09-30: Debt Securities, Available-for-sale $97.58M.
- 2024-06-30: Debt Securities, Available-for-sale $108.36M.
- 2024-03-31: Debt Securities, Available-for-sale $0.00.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2024-09-30 | $97.58M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $108.36M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-K · filed 2025-06-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |